Stock screener

ARDX

Conviction 56HealthcareScan · Thu, Jun 25, 2026
ARDX$6.06-2.10%
ResistanceSupportVol 14Insider sell
63 bars
19
Vol MA14 3.91M
Mar 26Apr 14May 1May 19Jun 8Jun 25
ARDELYX, INC.PHARMACEUTICAL PREPARATIONSwww.ardelyx.com
Price6.06
Change-2.10%
Gap+0.16%
Rel volume1.58×
Avg volume3.63M
Avg $ vol21.23M
SMA 205.81
SMA 506.15
SMA 2006.11
Price vs 50-1.47%
Price vs 200-0.82%
MA stackmixed
50/200 cross
Supertrendup · 5.46
RSI (14)52
MACD hist0.08
MACD crossbull · 6d
Stoch %K / %D62 / 70
ADX (14)18
+DI / −DI19 / 16
RSI divergence
MACD divergence
ATR %+4.76%
ADR %4.59%
52w high7.99
52w low3.63
From 52w high-24.16%
Above 52w low+66.94%
New 52w highNo
SqueezeOff
Bollinger width19.73%
%B0.72
Donchian pos64.66%
Donchian high6.47
Donchian low5.31
AVWAP (52w high)6.32
vs AVWAP high-4.15%
AVWAP (52w low)5.95
vs AVWAP low+1.81%
OBV trendFlat
Chaikin MF (20)-0.17
Today vs 20d1.58×
Avg vol (14d)3.91M
Avg vol (20d)3.63M
Avg $ vol (20d)21.23M
Market cap1.5B
RS 3m (vs SPY)+3.44%
RS 6m (vs SPY)+1.24%
RS line new highNo
Trend template4/8
Technical rank42.5
1 week+3.77%
1 month-3.04%
3 months+7.45%
6 months+3.77%
1 year+64.67%
YTD-1.46%
P/E-24.30
P/B10.07
P/S3.68
P/FCF-34.04
EPS-0.2600
Div yield
ROE-41.45%
ROA-12.21%
Debt/Eq0.18
Current3.49
EV/EBITDA-39.36
Gross margin1.15%
Net margin-15.12%
Rev growth22.09%
EPS growth-57.40%
Price target16.40
Target upside170.63%
Analyst ratingBuy
Institutional77.83%
Ent. value1.49B
Revenue94.47M
Net income-37.6M
Gross profit2.41M
Free cash flow-43.98M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out247.03M
Employees489
ListedThu, Jun 19, 2014
Free float235.27M
Float %96.8%
Short interest24.78M
Days to cover9.7d
Short volume48.1%
Squeeze score60 / 100
Next earningsMon, Aug 3, 2026 (39d)
EPS forecast−$0.03 · 4 est
Last EPS vs est−$0.15 vs −$0.13
Last surprise-15.4% miss
Setup gradeC
Conviction56 / 100
Pattern quality
Tech rank42.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance6.95
Support5.44
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ARDX

All disclosures →
No recent disclosed trades by Congress in ARDX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ARDX · 8 buys · 2 sells

InsiderSideShares
Williams Laura A
Chief Patient Officer · Common Stock · 2026-06-18
Exercise31K
Williams Laura A
Chief Patient Officer · Common Stock · 2026-06-18
Sell81.9K
Williams Laura A
Chief Patient Officer · Stock Option (Right to Buy) · 2026-06-18
Exercise31K
Bhanji Muna
Director · Common Stock · 2026-06-16
Grant26.45K
MOTT DAVID M
Director · Common Stock · 2026-06-16
Grant20.28K
MOTT DAVID M
Director · Common Stock · 2026-06-16
Grant26.45K
MOTT DAVID M
Director · Stock Option (Right to Buy) · 2026-06-16
Grant39.72K
Bertrand William C JR
Director · Common Stock · 2026-06-16
Grant12.35K
Bertrand William C JR
Director · Common Stock · 2026-06-16
Grant26.45K
Bertrand William C JR
Director · Stock Option (Right to Buy) · 2026-06-16
Grant39.72K

SEC filings

EDGAR filings in ARDX · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.